ALNY vs WASH · P/E 76, rev $1.29B vs P/E 13, rev $229.0M
Alnylam Pharmaceuticals Inc (ALNY) versus Washington Trust Bancorp Inc (WASH) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Washington Trust Bancorp Inc (WASH) is a banks - regional company listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported WASH revenue for 2025-12-31 was $229.0M. Net income was $52.2M. Revenue was up 127.6% from 2024-12-31 to 2025-12-31. WASH currently screens at market cap $657.0M and trailing P/E 12.6.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. WASH currently screens at market cap $657.0M and trailing P/E 12.6.
Not investment advice. Open the ALNY and WASH stock pages for the full models.
Not investment advice.